Iranian Journal of Diabetes and Obesity
Shahid Sadoughi University Of Medical Sciences
Tue, May 7, 2024
[Archive]
Volume 13, Issue 3 (volume 13, number 3 2021)
IJDO 2021, 13(3): 117-124 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Di Lorenzo M, Mascolo S, Romanelli A. Impact of COVID-19 Pandemic and Lockdown Measures on the Nutrition Plan Service Cohort. IJDO 2021; 13 (3) :117-124
URL: http://ijdo.ssu.ac.ir/article-1-641-en.html
URL: http://ijdo.ssu.ac.ir/article-1-641-en.html
2. Department of Infectious Diseases, AORN dei Colli, Cotugno Hospital, Napoli, Italy.
Abstract: (880 Views)
Objective: This study analyses the patients' factors can influence the attitude to follow or not the therapeutic weight-loss plan after national lockdown measures adopted from March 2020 to May 2020.
Materials and Methods: Patients that visited a private nutritional center in March 2020 were included in this retrospective observational study. All relevant characteristics were noted. In May 2020, patients who did not attend the follow-up visit were labeled as "abandoned". Variation in Body Mass Index (BMI) was noted in the second visit. Univariate logistic regression was performed to test the influence on dependent variables (lost follow-up). Odds Ratio (OR) was calculated. According to BMI distribution, we performed a Student T-test (α= 0.05) or Wilcoxon test (α= 0.05) to test BMI variation in patients that attended the follow-up visit. A P-value< 0.05 was considered statistically significant.
Results: Our population consisted of 77 patients, and 26 patients (33.8%, CI95% 23.4-45.4%) were labelled as "abandoned". Age≥ 54 years old (OR= 8.9048, CI95%:1.888-41.9822, P-value= 0.0057) and suffering from hypertension (OR= 4.8706, CI95%:1.4284-16.6076, P-value= 0.0114) were factors associated with the abandon follow-up visits. Wilcoxon test for BMI variation resulted statistically significant (May BMI 29.5 kg/m2 vs March BMI 29.4 kg/m2, P-value= 0.0094).
Conclusion: Age and hypertension are related to the risk of abandoning healthcare services after ending the national lockdown. The losing follow-up phenomenon could worsen clinical conditions and reduce life expectancy. An increase in BMI during lockdown should be interpreted as a personal difficulty in complying with therapeutic prescriptions.
Materials and Methods: Patients that visited a private nutritional center in March 2020 were included in this retrospective observational study. All relevant characteristics were noted. In May 2020, patients who did not attend the follow-up visit were labeled as "abandoned". Variation in Body Mass Index (BMI) was noted in the second visit. Univariate logistic regression was performed to test the influence on dependent variables (lost follow-up). Odds Ratio (OR) was calculated. According to BMI distribution, we performed a Student T-test (α= 0.05) or Wilcoxon test (α= 0.05) to test BMI variation in patients that attended the follow-up visit. A P-value< 0.05 was considered statistically significant.
Results: Our population consisted of 77 patients, and 26 patients (33.8%, CI95% 23.4-45.4%) were labelled as "abandoned". Age≥ 54 years old (OR= 8.9048, CI95%:1.888-41.9822, P-value= 0.0057) and suffering from hypertension (OR= 4.8706, CI95%:1.4284-16.6076, P-value= 0.0114) were factors associated with the abandon follow-up visits. Wilcoxon test for BMI variation resulted statistically significant (May BMI 29.5 kg/m2 vs March BMI 29.4 kg/m2, P-value= 0.0094).
Conclusion: Age and hypertension are related to the risk of abandoning healthcare services after ending the national lockdown. The losing follow-up phenomenon could worsen clinical conditions and reduce life expectancy. An increase in BMI during lockdown should be interpreted as a personal difficulty in complying with therapeutic prescriptions.
Type of Study: Research |
Subject:
Special
Received: 2021/09/14 | Accepted: 2021/09/19 | Published: 2021/09/19
Received: 2021/09/14 | Accepted: 2021/09/19 | Published: 2021/09/19
References
1. Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. Jama. 2020;323(20):2052-9. [DOI:10.1001/jama.2020.6775]
2. Gerst-Emerson K, Jayawardhana J. Loneliness as a public health issue: the impact of loneliness on health care utilization among older adults. American journal of public health. 2015;105(5):1013-9. [DOI:10.2105/AJPH.2014.302427]
3. Michalowsky B, Hoffmann W, Bohlken J, Kostev K. Effect of the COVID-19 lockdown on disease recognition and utilisation of healthcare services in the older population in Germany: a cross-sectional study. Age and Ageing. 2021;50(2):317-25. [DOI:10.1093/ageing/afaa260]
4. Munoz-Martínez S, Sapena V, Forner A, Nault JC, Sapisochin G, Rimassa L, et al. Assessing the impact of COVID-19 on liver cancer management (CERO-19). JHEP Reports. 2021;3(3):100260. [DOI:10.1016/j.jhepr.2021.100260]
5. Bedford J, Enria D, Giesecke J, Heymann DL, Ihekweazu C, Kobinger G, et al. COVID-19: towards controlling of a pandemic. The lancet. 2020;395(10229):1015-8. [DOI:10.1016/S0140-6736(20)30673-5]
6. Kendzerska T, Zhu DT, Gershon AS, Edwards JD, Peixoto C, Robillard R, et al. The effects of the health system response to the COVID-19 pandemic on chronic disease management: a narrative review. Risk Management and Healthcare Policy. 2021;14:575-84. [DOI:10.2147/RMHP.S293471]
7. Goumenou M, Sarigiannis D, Tsatsakis A, Anesti O, Docea AO, Petrakis D, et al. COVID 19 in Northern Italy: An integrative overview of factors possibly influencing the sharp increase of the outbreak. Molecular Medicine Reports. 2020;22(1):20-32. [DOI:10.3892/mmr.2020.11079]
8. Muscogiuri G, Barrea L, Savastano S, Colao A. Nutritional recommendations for CoVID-19 quarantine. European Journal of Clinical Nutrition. 2020;74(6):850-1. [DOI:10.1038/s41430-020-0635-2]
9. Petrakis D, Margina D, Tsarouhas K, Tekos F, Stan M, Nikitovic D, et al. Obesity a risk factor for increased COVID 19 prevalence, severity and lethality. Molecular medicine reports. 2020;22(1):9-19. [DOI:10.3892/mmr.2020.11127]
10. Ritter A, Kreis NN, Louwen F, Yuan J. Obesity and COVID-19: molecular mechanisms linking both pandemics. International journal of molecular sciences. 2020;21(16):5793. [DOI:10.3390/ijms21165793]
11. Yang J, Hu J, Zhu C. Obesity aggravates COVID‐19: a systematic review and meta‐analysis. Journal of medical virology. 2021;93(1):257-61. [DOI:10.1002/jmv.26237]
12. Donohoe CL, Lysaght J, O'Sullivan J, Reynolds JV. Emerging concepts linking obesity with the hallmarks of cancer. Trends in Endocrinology & Metabolism. 2017;28(1):46-62. [DOI:10.1016/j.tem.2016.08.004]
13. Petrakis D, Vassilopoulou L, Mamoulakis C, Psycharakis C, Anifantaki A, Sifakis S, et al. Endocrine disruptors leading to obesity and related diseases. International journal of environmental research and public health. 2017;14(10):1282. [DOI:10.3390/ijerph14101282]
14. Vassilopoulou L, Psycharakis C, Petrakis D, Tsiaoussis J, Tsatsakis AM. Obesity, persistent organic pollutants and related health problems. Obesity and Lipotoxicity. 2017:81-110. [DOI:10.1007/978-3-319-48382-5_4]
15. Andersen CJ, Murphy KE, Fernandez ML. Impact of obesity and metabolic syndrome on immunity. Advances in Nutrition. 2016;7(1):66-75. [DOI:10.3945/an.115.010207]
16. Febbraio MA. Role of interleukins in obesity: implications for metabolic disease. Trends in Endocrinology & Metabolism. 2014;25(6):312-9. [DOI:10.1016/j.tem.2014.02.004]
17. Louwen F, Ritter A, Kreis NN, Yuan J. Insight into the development of obesity: functional alterations of adipose‐derived mesenchymal stem cells. Obesity Reviews. 2018;19(7):888-904. [DOI:10.1111/obr.12679]
18. McLaughlin T, Ackerman SE, Shen L, Engleman E. Role of innate and adaptive immunity in obesity-associated metabolic disease. The Journal of clinical investigation. 2017;127(1):5-13. [DOI:10.1172/JCI88876]
19. Ellulu MS, Patimah I, Khaza'ai H, Rahmat A, Abed Y. Obesity and inflammation: the linking mechanism and the complications. Archives of medical science: AMS. 2017;13(4):851-63. [DOI:10.5114/aoms.2016.58928]
20. Exley MA, Hand L, O'Shea D, Lynch L. Interplay between the immune system and adipose tissue in obesity. Journal of Endocrinology. 2014;223(2):R41-8. [DOI:10.1530/JOE-13-0516]
21. Richard C, Wadowski M, Goruk S, Cameron L, Sharma AM, Field CJ. Individuals with obesity and type 2 diabetes have additional immune dysfunction compared with obese individuals who are metabolically healthy. BMJ Open Diabetes Research and Care. 2017;5(1):e000379. [DOI:10.1136/bmjdrc-2016-000379]
22. Moore JB, June CH. Cytokine release syndrome in severe COVID-19. Science. 2020;368(6490):473-4. [DOI:10.1126/science.abb8925]
23. Flanagan EW, Beyl RA, Fearnbach SN, Altazan AD, Martin CK, Redman LM. The impact of COVID‐19 stay‐at‐home orders on health behaviors in adults. Obesity. 2021;29(2):438-45. [DOI:10.1002/oby.23066]
24. Marchitelli S, Mazza C, Lenzi A, Ricci E, Gnessi L, Roma P. Weight gain in a sample of patients affected by overweight/obesity with and without a psychiatric diagnosis during the covid-19 lockdown. Nutrients. 2020;12(11):3525. [DOI:10.3390/nu12113525]
25. Robinson E, Boyland E, Chisholm A, Harrold J, Maloney NG, Marty L, et al. Obesity, eating behavior and physical activity during COVID-19 lockdown: A study of UK adults. Appetite. 2021;156:104853. [DOI:10.1016/j.appet.2020.104853]
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
